|
|
Eigene Publikationen zum Thema pKi-67:
Ich schicke
Ihnen auf Anfrage
gerne pdf-Versionen oder Kopien der Paper zu: EMAIL an
mich: mduchrow :-)
compuserve.de
Mein vollständiges
Schrift-Verzeichnis -> bitte hier klicken!
M. Duchrow
Klonierung,
Charakterisierung und Funktionsanalyse des proliferationsassoziierten
Ki-67
Antigens
Kumulative Habilitationsschrift
(Universität zu Lübeck,
Medizinische Fakultät, 2003)
Vollständige Schrift als
->
PDF Datei (1029 kb)
J.Gerdes, Li Li,
C.Schlüter, M.Duchrow, C.Wohlenberg, C.Gerlach, I.Stahmer,
S.Kloth, E.Brandt, and H.D.Flad
Immunobiochemical
and molecular biologic characterization of the cell
proliferation-associated nuclear antigen that is defined by monoclonal
antibody Ki-67
Am. J. Pathol. 138, 1991: 867 - 873
C.Fonatsch, M.Duchrow, H.Rieder, C.Schlüter, and J.Gerdes
Assignment
of the human Ki-67 gene (MKI67) to 10q25-qter
Genomics 11 (2), 1991: 467 - 477
J.Gerdes, C.Schlüter, M.Duchrow, Li Li, G.Key, C.Gerlach,
M.Becker, and H.-D.Flad
Recent
approaches to the characterization of the cell proliferation associated
nuclear antigen that is defined by monoclonal antibody Ki-67
In: G.Kindermann, B.Lampe (Hrg.), Immunhistochemische Diagnostik
gynäkologischer Tumoren, G.Thieme Verlag, 1992: 2 - 7
G.Key, F.Megetto, M.H.G.Becker, T.Al Saati, C.Schlüter, M.Duchrow,
G.Delsol, and J.Gerdes
Immunobiochemical
characterization of the antigen detected by monoclonal antibody
IND.64Evidence that IND.64 reacts with the cell proliferation
associated nuclear antigen previously defined by Ki-67
Virchows Archiv B Cell Pathol. 62, 1992: 259 – 261
G.Cattoretti, M.H.G.Becker, G.Key, M.Duchrow, C.Schlüter, J.Galle,
and J.Gerdes
Monoclonal
antibodies against recombinant parts of the Ki-67 antigen (MIB 1 and
MIB 3) detect proliferating cells in microwave processed formalin-fixed
paraffin sections
Journal of Pathol. 168, 1992: 357 - 363
G.Key, M.H.G.Becker, B.Baron, M.Duchrow, C.Schlüter, H.-D.Flad,
and J.Gerdes
New
Ki-67-equivalent murine monoclonal antibodies (MIB 1-3) generated
against bacterially expressed parts of the Ki-67 cDNA containing three
62 bp repetitive elements encoding for the Ki-67 epitope
Lab. Invest. 68, 1993: 629 - 636
C.Schlüter, M.Duchrow, C.Wohlenberg, M.H.G.Becker, G.Key,
H.-D.Flad, and J.Gerdes
The Cell
Proliferation-associated Antigen of Antibody Ki-67: A Very Large,
Ubiquitous Nuclear Protein with Numerous Repeated Elements,
Representing a New Kind of Cell Cycle-maintaining Proteins
J. Cell Biol. 123, 1993: 513 - 522
G.Key, J.L.Petersen, M.H.G.Becker, M.Duchrow, C.Schlüter, J.Askaa,
and J.Gerdes
New
antiserum against Ki-67 antigen suitable for double immunostaining of
paraffin wax sections
J. Clin. Pathol. 46, 1993: 1080 - 1084
M.Duchrow, J.Gerdes and C.Schlüter
The
Proliferation-Associated Ki-67 Protein: Definition in Molecular Terms
Cell Prolif. 27, 1994: 235 - 242
H.G.Kubbutat, G.Key, M.Duchrow, C.Schlüter, H.-D.Flad, and
J.Gerdes
Epitope
Analysis of antibodies recognizing the cell proliferation associated
nuclear antigen previously defined by the antibody Ki-67 (Ki-67 protein)
J. Clin. Pathol 47, 1994: 524 - 528
M.Duchrow, C,Schlüter und J.Gerdes
Molekularbiologische
Charakterisierung des proliferationsassoziierten Ki-67-Proteins
Focus MUL 11, 1994: 219 – 225
M.Duchrow, C.Schlüter, G.Key, M.H.G.Kubbutat,
C.Wohlenberg, H.-D.Flad, and J.Gerdes
Cell
proliferation-associated nuclear antigen defined by antibody Ki-67: a
new kind of cell cycle-maintaining proteins
Archivum Immunologiae et Therapiae Experimentalis 43, 1995: 117 - 121
M.Duchrow, C.Schlüter, C.Wohlenberg, H.-D.Flad, and J.Gerdes
Molecular
characterization of the gene locus of the human cell
proliferation-associated nuclear protein defined by monoclonal antibody
Ki-67
Cell prolif. 29, 1996: 1 – 12
R.Broll, C.Mahlke, R.Best, H.Schimmelpenning, M.W.Strik, T.Schiedeck,
H.-P.Bruch, and M.Duchrow
Assessment
of the proliferation index in gastric carcinomas with the monoclonal
antibody MIB-1.
J Cancer Res Clin Oncol 124, 1998: 49-54
M.Duchrow, S.Häsemeyer, R.Broll, H.-P.Bruch, and
U.Windhövel
Assessment of
proliferative activity in
colorectal carcinomas by quantitative RT‑PCR.
Cancer invest 19, 2001: 596-604; IF= 1,850
M.Duchrow,
M.H.H.Schmidt, M.Zingler, S.Anemüller, H.-P.Bruch, and
R.Broll
Suppression of Cell Division by
Ki-67
Antisense-RNA and Recombinant Protein
M.H.H.Schmidt, R.Broll, H.-P.Bruch, and M.Duchrow
The proliferation
marker pKi 67 becomes masked to MIB-1 staining after expression of its
tandem repeats
HISTOCHEM CELL BIOL 118: 415-422
(2002); IF= 2,054
M.H.H.Schmidt, R.Broll, H.-P.Bruch, and M.Duchrow
Proliferation marker
pKi-67 affects the cell cycle in a self-regulated manner
J
CELL BIOCHEM 87: 334-341 (2002); IF=
2,530
M.Duchrow, T.Ziemann, H.-P.Bruch, and R.Broll
Colorectal carcinomas
with high MIB-1 labeling indices but low pKi-67 mRNA levels correlate
with a better prognostic outcome
HISTOPATHOLOGY
42: 566-574 (2003); IF=
2,869
M.H.H.Schmidt, R.Broll, H.-P.Bruch, O.
Bögler and
M.Duchrow
The proliferation marker pKi 67
organizes the nucleolus during the cell cycle depending on Ran and
Cyclin B
J PATHOL 199: 18-27 (2003); IF= 4,536
T.Bubán
T, M.H.H.Schmidt, R.Broll,
P.Antal-Szalmás, M.Duchrow
Detection of mutations in the
cDNA of the proliferation marker Ki-67 protein in four tumor cell lines
J
Cell Biochem 91:
1280-1292 (2004); IF=
2,530
M.H.H.Schmidt, R.Broll, H.-P.Bruch, S.Finniss,
O.Bögler and M.Duchrow
Proliferation marker
pKi-67 occurs in different isoforms with various cellular effects
J
Cell Biochem 91:
1280-1292 (2004); IF=
2,530
T.Ihmann, J.Liu, W.Schwabe,
P.Häusler, D.Behnke, H.-P.Bruch,
R.Broll, and M.Duchrow
High level mRNA
quantification of proliferation marker pKi-67 is correlated with
favorable prognosis in colorectal carcinoma
J Cancer Res Clin Onc (2004; DOI
10.1007/s00432-004-0612-5); IF=
2,197
PDF Datei (565 kb) ->
Sonderdruck (reprint). The original publication is available at www.springerlink.com.
(http://www.springerlink.com/openurl.asp?genre=article&id=doi:10.1007/s00432-004-0612-5)
PDF Datei (3866 kb)
zu diesem
Thema: ->
Dissertationsarbeit von Dr.
Thomas Ihmann: "Vergleich
der pKi-67 Protein- mit der pKi-67 mRNA Expression mittels
Immunhistologie und Realtime RT-PCR in kolorektalen Karzinomen."
(IF= Impact
Faktor, SCI 2002)
(Für
den Inhalt externer Links sind
ausschließlich die jeweiligen Betreiber der Seiten verantwortlich)
|